Evidence map›Paper›PMID 34926315›Full record

ArticleFrontiers in cellular and infection microbiology2021

Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children.

Camilla Ceccarani, Ilaria Viganò, Emerenziana Ottaviano, Maria Gaia Redaelli, Marco Severgnini, Aglaia Vignoli, Elisa Borghi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exploring Gut Microbiota-Targeted Therapies for Canine Idiopathic Epilepsy.International journal of molecular sciences · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Camilla CeccaraniInstitute of Biomedical Technologies, National Research Council, Segrate, Italy.
Ilaria ViganòEpilepsy Centre, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo Carlo, University of Milan, Milan, Italy.
Emerenziana OttavianoDepartment of Health Sciences, University of Milan, Milan, Italy.
Maria Gaia RedaelliEpilepsy Centre, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo Carlo, University of Milan, Milan, Italy.
Marco SevergniniInstitute of Biomedical Technologies, National Research Council, Segrate, Italy.
Aglaia VignoliDepartment of Health Sciences, University of Milan, Milan, Italy.
Elisa BorghiDepartment of Health Sciences, University of Milan, Milan, Italy.
University of Milan · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiota alterations have been recently investigated in individuals with epilepsy and in other neurological diseases as environmental factors that play a role, by acting through the gut-brain axis, in the pathological process. Most studies focus on the contribution of bacterial communities in refractory epilepsy and suggest a beneficial role of ketogenic diet in modulating the gut microbiota and seizure occurrence. However, they do not evaluate whether epilepsy itself alters the gut microbiota in these patients or if the gut microbial communities could contribute as a seizure trigger. In this pilot study, we performed 16S rRNA sequencing and investigated the gut microbial communities of eight children at their seizure onset and after anti-seizure was started (one year follow-up) and we compared microbial data with seven healthy children, age- and sex-matched. In drug-naive subjects, we observed a microbial signature that shared several features with those reported in refractory epilepsy, such as an increased abundance in

Indexed as

EpilepsyGastrointestinal MicrobiomePharmaceutical PreparationsBrain-Gut AxisChildHumansLongitudinal StudiesPilot ProjectsRNA, Ribosomal, 16SPharmaceutical PreparationsRNA, Ribosomal, 16SAkkermansiaanti-seizure medicationepilepsygut microbiotainflammationProteobacteriaseizures

Identifiers

PMID34926315
PMCPMC8677705
OpenAlexW3215032107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.